$NKE have reported and I have shared their ER details in the Research Group, the headlines will show a strong beat on the EPS and revenue estimates
But we are not looking for miracles here, the share price is at a 5 year low because of declining sales and what we want to see now is a trend change back to growth, so it is a good start that $NKE has beaten Wall St estimates.
Also, you are still very early here and we are still in the Buy Zone.
The lower risk entry would be to add above the 200 Day MA at $79 but many members have added on this pull back already.
Long Term I believe $NKE will return to former glory levels and outperform the market in 2025.
Matt
2025-03-21 12:16:54 +0000 UTCJohn Keys
2025-03-21 07:22:29 +0000 UTCDante
2025-03-20 20:56:22 +0000 UTC